“Who on the executive team has brought a fda app
Post# of 148319
Let me put this in simple terms for you: if the FDA approves leronlimab for COVID19 or HIV combo therapy later this year, NP and the rest of the CYDY crew will have brought a $1 billion drug to market. The Vyera deal covers distribution for HIV and there will be a distribution deal for COVID as well, which covers the remaining bases.
My point: we don’t need a new CEO to get to revenue as leronlimab is only an approval away from profits.